TriangleFOR PATIENTS · SOURCE READING
Treatment of Acute Lymphoblastic Leukemia in Remission
Source: Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Treatment of ALL during the post-remission phase includes:
Source links and citations
chemotherapy
Source links and citations
targeted therapy with dasatinib, imatinib, or nilotinib
Source links and citations
chemotherapy with stem cell transplant
Source links and citations
central nervous system (CNS prophylaxis) including chemotherapy (intrathecal and/or systemic) with or without radiation therapy to the brain
Source links and citations
Learn more about these treatments in the Treatment Option Overview.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice